JP2023509463A5 - - Google Patents

Info

Publication number
JP2023509463A5
JP2023509463A5 JP2022541285A JP2022541285A JP2023509463A5 JP 2023509463 A5 JP2023509463 A5 JP 2023509463A5 JP 2022541285 A JP2022541285 A JP 2022541285A JP 2022541285 A JP2022541285 A JP 2022541285A JP 2023509463 A5 JP2023509463 A5 JP 2023509463A5
Authority
JP
Japan
Prior art keywords
particles
therapeutic
therapeutic agent
group
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022541285A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023509463A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/012015 external-priority patent/WO2021138646A1/en
Publication of JP2023509463A publication Critical patent/JP2023509463A/ja
Publication of JP2023509463A5 publication Critical patent/JP2023509463A5/ja
Priority to JP2025153243A priority Critical patent/JP2025178320A/ja
Pending legal-status Critical Current

Links

JP2022541285A 2020-01-03 2021-01-03 細胞の標的集団の直接注射による治療のためのシステム及び医薬組成物 Pending JP2023509463A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025153243A JP2025178320A (ja) 2020-01-03 2025-09-16 細胞の標的集団の直接注射による治療のためのシステム及び医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062956795P 2020-01-03 2020-01-03
US62/956,795 2020-01-03
PCT/US2021/012015 WO2021138646A1 (en) 2020-01-03 2021-01-03 Systems and pharmaceutical compositions for treatment by direct injection of a targeted population of cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025153243A Division JP2025178320A (ja) 2020-01-03 2025-09-16 細胞の標的集団の直接注射による治療のためのシステム及び医薬組成物

Publications (2)

Publication Number Publication Date
JP2023509463A JP2023509463A (ja) 2023-03-08
JP2023509463A5 true JP2023509463A5 (cg-RX-API-DMAC7.html) 2024-01-11

Family

ID=76687575

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022541285A Pending JP2023509463A (ja) 2020-01-03 2021-01-03 細胞の標的集団の直接注射による治療のためのシステム及び医薬組成物
JP2025153243A Pending JP2025178320A (ja) 2020-01-03 2025-09-16 細胞の標的集団の直接注射による治療のためのシステム及び医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025153243A Pending JP2025178320A (ja) 2020-01-03 2025-09-16 細胞の標的集団の直接注射による治療のためのシステム及び医薬組成物

Country Status (9)

Country Link
US (1) US20230103552A1 (cg-RX-API-DMAC7.html)
EP (1) EP4084828A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023509463A (cg-RX-API-DMAC7.html)
KR (1) KR20220125798A (cg-RX-API-DMAC7.html)
CN (2) CN115243722A (cg-RX-API-DMAC7.html)
AU (1) AU2021204918A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022013270A2 (cg-RX-API-DMAC7.html)
CA (1) CA3166633A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021138646A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10398655B2 (en) 2016-02-18 2019-09-03 Privo Technologies, Inc. Two-stage microparticle-based therapeutic delivery system and method
US20180235899A1 (en) 2017-02-17 2018-08-23 Privo Technologies, Inc. Particle-based multi-layer therapeutic delivery device and method
US10478403B1 (en) 2017-05-03 2019-11-19 Privo Technologies, Inc. Intraoperative topically-applied non-implantable rapid release patch
PE20240329A1 (es) 2019-06-05 2024-02-27 Regeneron Pharma Dispositivos y metodos para administracion de dosis de precision
KR20240041285A (ko) 2021-06-01 2024-03-29 프리보 테크놀로지스, 인코포레이티드 향상된 2단계 미세입자 기반 국소 치료제 전달 시스템
US12649031B2 (en) 2021-09-08 2026-06-09 Regeneron Pharmaceuticals, Inc. Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation
USD1120314S1 (en) 2022-11-30 2026-03-24 Regeneron Pharmaceuticals, Inc. Dose delivery device
KR20250123284A (ko) 2024-02-07 2025-08-18 순천향대학교 산학협력단 클릭화학을 이용한 약물 봉입 엑소좀 유사체의 제조 방법 및 약물 봉입 엑소좀 유사체
CN121221639A (zh) * 2025-10-11 2025-12-30 中山大学附属第五医院 一种负载难溶性中药小分子阿可拉定hp@ict水凝胶、及其制备方法与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960016882A (ko) * 1994-11-01 1996-06-17 강재헌 치주염치료를 위한 서방출형 생분해성 제제
CZ20023333A3 (cs) 2000-04-10 2003-06-18 Teva Pharmaceutical Industries Ltd. Léčivo pro léčení rakoviny
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
CA2582374A1 (en) * 2004-10-04 2006-04-20 Qlt Usa, Inc. Ocular delivery of polymeric delivery formulations
US7867984B1 (en) * 2005-01-04 2011-01-11 Gp Medical, Inc. Nanoparticles for protein drug delivery
US8242165B2 (en) * 2006-10-26 2012-08-14 Creighton University Mucoadhesive nanoparticles for cancer treatment
EP2152315B1 (en) * 2007-05-25 2016-01-06 Indivior UK Limited Sustained delivery formulations of risperidone compounds
AU2009262896B2 (en) * 2008-05-30 2015-04-02 Allergan, Inc. Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form
EP2306991B1 (en) * 2008-06-27 2019-12-25 Tepha, Inc. Injectable delivery of microparticles and compositions therefore
WO2016004213A2 (en) * 2014-07-01 2016-01-07 Vicus Therapeutics, Llc Hydrogels for treating and ameliorating cancers and potentiating the immune system and methods of making and using them
US10398655B2 (en) * 2016-02-18 2019-09-03 Privo Technologies, Inc. Two-stage microparticle-based therapeutic delivery system and method
US20180235899A1 (en) * 2017-02-17 2018-08-23 Privo Technologies, Inc. Particle-based multi-layer therapeutic delivery device and method
US10478403B1 (en) * 2017-05-03 2019-11-19 Privo Technologies, Inc. Intraoperative topically-applied non-implantable rapid release patch

Similar Documents

Publication Publication Date Title
TWI732773B (zh) 用於奈米顆粒冷凍乾燥形式的組成物及方法
EP2817011B1 (en) Treatment of cancer
US9724421B2 (en) Chemoembolization composition comprising anti-angiogenic agents
JP2022531939A5 (cg-RX-API-DMAC7.html)
JP2018138578A5 (cg-RX-API-DMAC7.html)
TW201711697A (zh) 抗-cgrp抗體調配物
TWI813571B (zh) 防沉澱的小分子藥調配物
JP2023120445A (ja) テルリプレシン組成物およびその使用方法
CN115243722A (zh) 通过直接注射靶细胞群进行治疗的系统和药物组合物
JP2016155826A (ja) 経口薬物療法のための方法および組成物
CN112004528B (zh) 载药微珠组合物、栓塞组合物和相关方法
CN104306325A (zh) 一种抗肿瘤水凝胶的制备方法
JP5698296B2 (ja) 静脈内投与による有効成分制御放出のための生体適合性を有するアルギン酸微粒子組成物
US20150148385A1 (en) Pharmaceutical composition containing a compound having a thrombopoietin receptor agonistic activity
Si et al. Photonanozyme–Kras–ribosome combination treatment of non-small cell lung cancer after COVID-19
WO2019170912A1 (en) Bioresorbable controlled-release compositions with sting modulating molecules
WO2026060885A1 (zh) 一种生物相容性良好的控释释药微针及其制备方法
WO2020010616A1 (zh) 用于内镜手术的组合
CN105999273A (zh) 一种用于关节炎治疗的复方制剂
CN104546722A (zh) 米铂脂质体和制法
JP6549107B2 (ja) がんの処置のための、ro5503781、カペシタビン及びオキサリプラチンの組み合わせ
JP2006528185A (ja) 抗生物質製剤、その使用法及び作成方法
CN101181232B (zh) 一种治疗实体肿瘤的马赛替尼缓释植入剂
Zhang et al. Advancements in neovascular ophthalmopathy: therapeutic strategies and future prospects
CN102670611A (zh) 抗结核药物三联复方微球血管靶向栓塞缓释剂及其制备方法和用途